Methotrexate Induced Lung Toxicity-A Case Report
[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may migh...
Gespeichert in:
Veröffentlicht in: | Research journal of pharmacy and technology 2017-10, Vol.10 (10), p.3458-3460 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3460 |
---|---|
container_issue | 10 |
container_start_page | 3458 |
container_title | Research journal of pharmacy and technology |
container_volume | 10 |
creator | Lekshmi, S Sandhya Antony, Remya Sidharthan, Neeraj Kammath, Gireesh Anila, K. N |
description | [1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for < 2 months * During initial evaluation, Oxygen saturation < 90% on room air. * DLCO < 70% of predicted * < 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports: |
doi_str_mv | 10.5958/0974-360X.2017.00617.5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2048070483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2048070483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</originalsourceid><addsrcrecordid>eNo9kFtLxDAQhYMouKz7F6Tgc-ukaW6PS_GyUBFkBd9CmybaRduapLD77013ZefhzIE5zDAfQrcYMiqpuAfJi5Qw-MhywDwDYFHpBVqcB5dnj8U1Wnm_g1hM0LwQCwQvJnwNwZl9HUyy6dtJmzappv4z2Q77TnfhkK6TsvYmeTPj4MINurL1tzer_75E748P2_I5rV6fNuW6SjWWIqSGSq5lAbml0XFNWMMBW9JqC4zihpIaJDU2B1FLYXhM4lY2rLXMtowXZInuTntHN_xOxge1GybXx5Mqh0IAj0Jiip1S2g3eO2PV6Lqf2h0UBjUDUvPvauagZkDqCEhR8gfCGVay</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2048070483</pqid></control><display><type>article</type><title>Methotrexate Induced Lung Toxicity-A Case Report</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</creator><creatorcontrib>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</creatorcontrib><description>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for < 2 months * During initial evaluation, Oxygen saturation < 90% on room air. * DLCO < 70% of predicted * < 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2017.00617.5</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Acids ; Case reports ; Chemotherapy ; Cytotoxicity ; Drug dosages ; Fever ; Immune system ; Infections ; Lung diseases ; Lymphoma ; Orthopedics ; Patients ; Pneumonia ; Rheumatoid arthritis ; Tomography</subject><ispartof>Research journal of pharmacy and technology, 2017-10, Vol.10 (10), p.3458-3460</ispartof><rights>Copyright A&V Publications Oct 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lekshmi, S Sandhya</creatorcontrib><creatorcontrib>Antony, Remya</creatorcontrib><creatorcontrib>Sidharthan, Neeraj</creatorcontrib><creatorcontrib>Kammath, Gireesh</creatorcontrib><creatorcontrib>Anila, K. N</creatorcontrib><title>Methotrexate Induced Lung Toxicity-A Case Report</title><title>Research journal of pharmacy and technology</title><description>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for < 2 months * During initial evaluation, Oxygen saturation < 90% on room air. * DLCO < 70% of predicted * < 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</description><subject>Acids</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Drug dosages</subject><subject>Fever</subject><subject>Immune system</subject><subject>Infections</subject><subject>Lung diseases</subject><subject>Lymphoma</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Rheumatoid arthritis</subject><subject>Tomography</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kFtLxDAQhYMouKz7F6Tgc-ukaW6PS_GyUBFkBd9CmybaRduapLD77013ZefhzIE5zDAfQrcYMiqpuAfJi5Qw-MhywDwDYFHpBVqcB5dnj8U1Wnm_g1hM0LwQCwQvJnwNwZl9HUyy6dtJmzappv4z2Q77TnfhkK6TsvYmeTPj4MINurL1tzer_75E748P2_I5rV6fNuW6SjWWIqSGSq5lAbml0XFNWMMBW9JqC4zihpIaJDU2B1FLYXhM4lY2rLXMtowXZInuTntHN_xOxge1GybXx5Mqh0IAj0Jiip1S2g3eO2PV6Lqf2h0UBjUDUvPvauagZkDqCEhR8gfCGVay</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Lekshmi, S Sandhya</creator><creator>Antony, Remya</creator><creator>Sidharthan, Neeraj</creator><creator>Kammath, Gireesh</creator><creator>Anila, K. N</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20171001</creationdate><title>Methotrexate Induced Lung Toxicity-A Case Report</title><author>Lekshmi, S Sandhya ; Antony, Remya ; Sidharthan, Neeraj ; Kammath, Gireesh ; Anila, K. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c198t-e597c9402f55977c36b701f3dcf0651b53a095ef208a98e74021d9b6df6fd6743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acids</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Drug dosages</topic><topic>Fever</topic><topic>Immune system</topic><topic>Infections</topic><topic>Lung diseases</topic><topic>Lymphoma</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Rheumatoid arthritis</topic><topic>Tomography</topic><toplevel>online_resources</toplevel><creatorcontrib>Lekshmi, S Sandhya</creatorcontrib><creatorcontrib>Antony, Remya</creatorcontrib><creatorcontrib>Sidharthan, Neeraj</creatorcontrib><creatorcontrib>Kammath, Gireesh</creatorcontrib><creatorcontrib>Anila, K. N</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lekshmi, S Sandhya</au><au>Antony, Remya</au><au>Sidharthan, Neeraj</au><au>Kammath, Gireesh</au><au>Anila, K. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methotrexate Induced Lung Toxicity-A Case Report</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>10</volume><issue>10</issue><spage>3458</spage><epage>3460</epage><pages>3458-3460</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[1] In patients with medication-induced lung toxicity, the radiologic patterns are highly variable and it rely upon the sort of antagonistic response the patient is experiencing. Since the vast majority of the medication prompted lung toxicities like the interstitial infiltrates, parenchyma may might be exhibited on radiographs. [3] Major criteria are as follows: * Hypersensitivity pneumonitis in view of histopathology, without confirmation of pathogenic organisms * Radiologic evidence of alveolar or pulmonary interstitial infiltrates. * Negative blood cultures (if febrile) and initial sputum cultures (if sputum is produced) Minor criteria are as follows: * Cough that are non-productive * Shortness of breath for < 2 months * During initial evaluation, Oxygen saturation < 90% on room air. * DLCO < 70% of predicted * < 15,000 cells/pL of leukocyte count There are very few studies in similar occurrence. In this case study, patient showed better clinical presentation after the cessation of the culprit, high dose methotrexate, Prompt diagnosis is vital in cases like above, in light of the fact that early medication-induced lung damage will frequently relapse with the end of treatment. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports:</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2017.00617.5</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0974-3618 |
ispartof | Research journal of pharmacy and technology, 2017-10, Vol.10 (10), p.3458-3460 |
issn | 0974-3618 0974-360X 0974-306X |
language | eng |
recordid | cdi_proquest_journals_2048070483 |
source | EZB-FREE-00999 freely available EZB journals |
subjects | Acids Case reports Chemotherapy Cytotoxicity Drug dosages Fever Immune system Infections Lung diseases Lymphoma Orthopedics Patients Pneumonia Rheumatoid arthritis Tomography |
title | Methotrexate Induced Lung Toxicity-A Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A40%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methotrexate%20Induced%20Lung%20Toxicity-A%20Case%20Report&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Lekshmi,%20S%20Sandhya&rft.date=2017-10-01&rft.volume=10&rft.issue=10&rft.spage=3458&rft.epage=3460&rft.pages=3458-3460&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2017.00617.5&rft_dat=%3Cproquest_cross%3E2048070483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2048070483&rft_id=info:pmid/&rfr_iscdi=true |